Member Info for MickTKipper

b>BUZZ – European Retail: COVID – 19 to reshape retail permanently – MS
12-05-2020 09:37

* Morgan Stanley does not see easing of lockdown measures as the beginning of the end of COVID-19's impact on the retail industry and keeps its cautious stance
* It expects sector earnings in 2020 and 2021 to be 62% and 33% lower, respectively, than those delivered in 2019
* MS says that the changes to consumers' lifestyles, and thus their spending behaviour, are likely to last much longer than until a vaccine becomes widely available
* "The strength of the balance sheet, how it will be impacted by ongoing social distancing measures, how cyclical it is, how deep the recession is going to be, and how consumer behaviour changes longer term" is what will determine the stocks' value, MS says
* The broker names AB Foods , Kingfisher , Marks & Spencer as its new top picks
* It cuts Boohoo and Dunelm to "underweight" seeing them as overvalued and moves all other companies in its coverage to "equal-weight"
(daria.kowalewska

BRIEF – FRP Advisory Group Says Have Not Furloughed Any Staff And Do Not Intend To
12-05-2020 08:10
May 12 (Reuters) – Frp Advisory Group PLC :

Full Year Trading Update
Have Not Furloughed Any Staff And Do Not Intend To, With Our Team Remaining Busily Engaged In Active Projects
Expects To Report Revenues For Half Year To 30 April 2020 Of £31.8m
Source text for Eikon: ... Further company coverage: FRP.L

(Reuters.Briefs@thomsonreuters.com;)

REG – FRP Advisory Grp PLC – Full Year Trading Update
12-05-2020 07:00
For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200512:nRSL5614Ma

RNS Number : 5614M FRP Advisory Group PLC 12 May 2020

12 May 2020

FRP ADVISORY GROUP PLC

("FRP", the "Group" or the "Company")



Full Year Trading Update



FRP Advisory Group plc, a leading UK professional services firm specialising
in advisory services, today announces a trading update for the year ended 30
April 2020.

COVID-19

Since the outbreak of the COVID-19 pandemic, the health, safety and wellbeing
of our colleagues has remained a top priority for the Board. We are pleased
that our business continuity plan has enabled our team to successfully move to
a working from home model and continue to provide the level of service
expected by the Group's clients during this challenging time. We have not
furloughed any staff and do not intend to, with our team remaining busily
engaged in active projects.

Trading performance

The Group traded strongly during the second half of the year to 30 April 2020,
continuing to grow caseloads in both size and complexity, with a number of
high-profile appointments during the period in the Group's Restructuring
division, including the administrations of Carluccios and Debenhams.

As a result, the Group expects to report revenues for the half year to 30
April 2020 of £31.8m, including revenues of £11.5m in the two months
following the successful IPO. Profits in both these periods are ahead of the
Board's expectations. The Group therefore expects to report revenues of
£63.2m for the year to 30 April 2020, up 16.4% versus the same period last
year (£54.3m).

Balance sheet

The Group retains a strong balance sheet, given £19m (net) of new money
proceeds from the IPO, and has an undrawn revolving credit facility of £5m.

Given the trading performance and strong balance sheet, the Group intends to
pay a final dividend for the period since IPO in line with its stated dividend
policy.

Board

The Board has today been notified by Kate O'Neill (Non-Executive Director)
that due to changes in her personal circumstances she intends to step down
from the Board at the end of June 2020. A search is now underway to identify
a suitable replacement and an update will be provided in due course.

Notice of results

The Group will report its full year results for the twelve months ended 30
April 2020 in late August. A further announcement confirming the date will be
made in due course.

Geoff Rowley, Chief Executive Officer of FRP Advisory Group plc, said:



"We're pleased to have delivered a strong performance over the year, while
successfully completing our milestone IPO at the beginning of March. With an
increasingly uncertain economic landscape, we believe the Group is well
positioned both

BATM.....bvc.....kemche...........still plenty to go for.............not just health sector either.

Easily a bagger for the calendar year.......................

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^BVC&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Found that tip sheet 2020 NAP article on BVC BATM was on the IG forum.........said they werent just a health/bio company......

BATM (BVC; 39p) said in September it was “on track for significantly higher revenue and improved margins in H2.” BATM’s most interesting bit is work it is doing in Network Function Visualisation across Software Defined Networks (SDN/NFV) with Arm, whose microprocessors run most modern smartphones. The potential for BATM here is that of the ‘Internet of things’ (IoT). Arm’s ‘Neoverse’ strategy is based on the arrival of much faster 5G connected networks, which are expected to link up many smart, connected devices as well as self-driving cars. With IoT devices generating massive amounts of data, the way to deal with it is to process it at the edge and send only what’s critical upstream and NFV assists this. Arm has enticed major cloud service providers to partner on the project (Amazon and Microsoft).Ends

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^BVC&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

CDM Codemasters gaming company........at last its woken up after about 2 weeks sleep.

Latest broker views

Date Broker Recomm. Current Price Price when issued Old price New price
30 Apr 20 Liberum Capital Buy 285.00 272.50 370.00 -
16 Apr 20 Peel Hunt Buy 285.00 260.00 375.00

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^CDM&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Most certainly. Dont forget Marks and Spencer hop aboard 1st of September. Should re- rate going up to then and new wharehouse nearlly completed.

OCDO Ocado.....new leg up on its way.

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^OCDO&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=20&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

ESP Empiric Student Property......

Broker Views. present SP 65.6p

Latest broker views

Date Broker Recomm. Current Price Price when issued Old price New price
11 Feb 20 Berenberg Hold 66.20 103.00 105.00 -
06 Feb 20 Berenberg Hold 66.20 101.40 - 105.00
05 Feb 20 Numis Hold 66.20 100.40 96.00

Fundamentals and health

Market capitalisation £352.85m
Shares in issue 603.16m
PE ratio 6.44
EPS 9.08p
EPS growth 35.93%
ROCE 5.64%
Quick ratio 0.31
Current ratio 0.31
Total dividends per share 5
Dividend yield 8.55%
Dividend cover 1.82

ESP Empiric Student Property.......bullish update yesterday.......

https://www.investegate.co.uk/empiric-student-prop--esp-/rns/trading-update/202005060700060362M/

Morning Star Report...

Empiric Student Property Outlook Confident As Secures New Bookings(Alliance News) -
Alliance News6 May, 2020 | 10:58AMEmail Form

(Alliance News) - Empiric Student Property PLC on Wednesday said it expects to report a double-digit fall in revenue this academic year, but continues to see demand for accommodation for the forthcoming academic year.

The student accommodation provider said its buildings continue to be staffed and maintained despite the lockdown.

However, the company said it expects a total reduction in income for the current academic year of up to 12% - about GBP8 million - which is short of the worst-case-scenario reduction in revenue of up to GBP21 million previously announced by the company.

Empiric explained that it has released from rent and lease obligations residents who are either no longer in occupation or, due to university closures, plan not to return to their accommodation.

However, the company noted that 55% of its student accommodation bedrooms continue to be occupied by residents despite university closures.

Looking ahead, Empiric said it continues to receive bookings for the forthcoming academic year, with 47% of rooms now reserved, compared with 54% at the same point last year.

Demand from international students is continuing, albeit at lower levels, but the company said it is starting to see an increase in bookings from the UK domestic market.

The company also noted that its 52-bed development at New Walk in Leicester is expected to complete later this month, in time for the forthcoming academic year.

However, given Empiric's priority of conserving cash during this period of uncertainty, the company said it has deferred the delivery of further three developments until market conditions stabilise.

"Empiric's strategy of owning and operating premium student accommodation in high-demand towns and cities combined with a strong and robust balance sheet puts the group in a strong position to withstand the challenges presented by the Covid-19 pandemic," the company said in its statement Wednesday.

Empiric shares were trading 6.5% higher in London on Wednesday at 62.28 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^ESP&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

MPAC GROUP.....

LATEST REPORTS

Mpac - Well placed and cash rich
Published: 6th May 2020

Mpac is well placed to survive the COVID-19 induced downturn, exploit opportunities that arise and flourish when the economy eventually gets back on its feet. With a £18.1m net cash balance (or 89p/share as at Feb’20), on top of an undrawn £10m credit facility, this provides ample fire-power to not only weather even the most extreme of scenarios, but also take advantage if some less well capitalised rivals ever became available at distressed levels.

Mpac have reduced/deferred capex (£2.3m 2019) and discretionary spend, alongside utilising government aid. They have, however, remained mindful not to harm the long term design and operational capability.

With regards to valuation, the stock at 235p remains attractively priced - trading on a 2019 EV/EBIT multiple of 7.4x (see below) vs 11x–15x typically for peers (pre CV19).
Sure the coronavirus will impact 2020 numbers, yet ultimately we believe Mpac will prosper. Benefitting from secular tailwinds (eg Industry 4.0, Direct-to-consumer deliveries), improving margins, a large installed base, positive cashflows and a host of loyal, blue-chip customers.

https://research.equitydevelopment.co.uk/research/well-placed-and-cash-rich?utm_campaign=Mpac&utm_source=hs_email&utm_medium=email&utm_content=87483000&_hsenc=p2ANqtz-8FWkAgxBt-Ge6XdRx94rO1CrXEWmu65oPABH0mdJLwH1DXquktPBzDNZfLSnuZWzRGmo7U_rwdCKxWUysmCGwy-HnB3w&_hsmi=87483000

OCDO OCADO citywire comment 7th May

Peel Hunt: more to come from Ocado

There will be ‘a lot more to come’ from online grocery platform Ocado (OCDO), which has been benefiting from the Covid-19 lockdown, says Peel Hunt.

Analyst James Lockyer retained his ‘buy’ recommendation and target price of £17.00 on the shares, which rose 5.6% to £17.73 yesterday.

Lockyer said Ocado delivered a ‘very positive surprise performance’ as sales surged 40% in the second quarter proving ‘online food delivery is a vital public service’ that will likely become permanent.

He said the company had proved its ‘ability to ramp up to cope with demand’ providing confidence in future growth and ‘the positive withdrawal of its guidance for the rest of the year shows that there is a lot more to come from Ocado’.

BVC BATM Advanced Communications................its got everything in its kit for the Virus...... Ventilators and Test kits and is selling them in quantity to countries around the World. THEY ARE NOT AWAITING FOR THERE PRODUCTS TO BE APPROVED...they have already been approved check the RNS thread out. This is a little gold mine of a company.

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^BVC&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^BVC&type=4&size=3&period=13&date1_year=2001&date1_month=01&date1_day=05&date2_year=2020&date2_month=05&date2_day=06&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=200&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

The full text here.........

https://www.***************************/ocado-group-remains-in-a-strong-position-with-growth-expansion-and-increased-demand/412818686

Ocado Group remains in a strong position with growth, expansion and increased demand
Posted by: Amilia Stone 6th May 2020

Ocado Group plc (LON:OCDO) today issued the following updates on current trading, on behalf of Ocado Retail Limited, Ocado Group’s joint venture with M&S, and a business update for Group, to coincide with the company’s Annual General Meeting taking place later today.

Tim Steiner, Ocado Group CEO, said,

“First of all, I would like to thank my colleagues across the business for their hard work, dedication and perseverance. This continues to be a very challenging time for everybody in the world and we are committed to doing our part to help get through this crisis.

We are facing quite a different challenge to many, as we scale up Ocado.com to play its part in feeding the nation, and as we help our clients launch and roll out their online businesses more rapidly against a backdrop of a likely long term increase in demand for online.

Ocado remains in a strong position and while we should be grateful that our current challenges are around growth, expansion and increased demand, we have great empathy for all who are facing different challenges at this time. In retail, we are working with our small suppliers to make sure we pay them earlier than normal and we will work closely with any who are struggling”.

Update on Ocado Retail

Throughout the ongoing COVID-19 crisis, Ocado Retail has shown great resilience in its efforts to meet the needs of as many customers in the UK as possible. At the beginning of the outbreak demand increased significantly, almost overnight. Although this has required difficult proactive decisions as we have prioritised our most vulnerable and our most loyal customers, we have adapted our platform rapidly in order to meet unprecedented demand and are now delivering significantly more groceries to households than ever before.

Operating our Retail business safely for our colleagues and customers has been our number one priority. We are protecting customers and colleagues with, amongst many changes, introducing contact-free deliveries to the doorstep of customers’ homes, carrying out temperature monitoring at all our CFC and spoke facilities, and now regular testing of our frontline staff for COVID-19. We are also recognising the exceptional contribution of our front line colleagues by giving them a 10% bonus during this period.

Growth in Retail Revenue in the Second Quarter to date is 40.4% up on last year, compared to 10.3% growth in the First Quarter. The number of items per basket appears to have passed its peak but remains high, as more normal shopping behaviours have returned, and the share of fresh and chilled products in the mix, relative to ambient, is also returning to normal.

We continue to price match individual products against our key competitors with the proportion of sales on promotion initially declining in order to discourage stockpiling in line with the industry. Ou

https://www.***************************/avacta-group-qa-covid-19-adeptrix-antigen-test-should-be-ready-by-summer-lonavct/412819400

"The near-term outlook is dominated by the prospect of launching a SARSCoV-2 mass screening point-of-care antigen test, using a lateral flow device, in the summer, the demand for which is likely to be in the 10s of millions. ? Forecasts and valuation. We have made minor changes to FY 2020 forecasts and leave our target price under review. Modelling the potential impact of a COVID-19 antigen test with any degree of confidence at the moment is not possible; however, the upside, if a successful test(s) is/are developed is/are considered substantial, as illustrated by the £250m+ incremental value created by Novacyt’s COVID PCR test."

Broker Finncap note on AVCT.........looks very bullish .

Avacta* FY 2019 results – building substantial incremental value

Full-year results (17 months) to 31 December 2019 were in line with expectations, with a year-end cash balance of £8.8m (FC est. £8.7m). Despite the disruption caused by the COVID-19 pandemic, Avacta has a cash runway into 2022, by which time it should have delivered at least two transformational value inflection points in each of the Therapeutics and Diagnostic business units. Pursuing a proprietary and partnership approach creates potential substantial incremental value, as evidenced by the four therapeutic and three diagnostics partnerships, whilst enabling Avacta to focus on its lead programme, which is now expected to enter Phase I trials in late 2020 or early 2021. We consider Avacta to be at a very exciting point in its evolution, with multiple significant valuation drivers. ? Results. A net loss of £15.6m was reported based on revenues of £5.5m (vs. £2.7m) Adjusting for share-based payments, the adjusted net loss amounted to £15.3m. Cash at 31 December 2019 was £8.8m, which together with the April fundraise (£5.4m) and projected R&D tax rebate (£2.5m), provides a cash runway into 2022. ? Therapeutics – transformational year. Avacta now expects, given COVID-related issues, to file a CTA in Q3 2020 for AVA6000 with the intention to start a Phase I trial in late 2020 or early 2021, potentially creating a proprietary blockbuster chemotherapy for advanced soft tissue sarcoma and other cancers, and validating the pre|CISION technology in humans. Avacta has identified a second asset, having generated interesting animal efficacy data in pancreatic cancer model, to potentially take into the clinic in late 2021 if funding is available. A further 9 targeted chemotherapies have also been formulated whilst first TMAC animal data is also very encouraging. ? Diagnostics – significant commercial progress. The SARS-CoV-2 antigen test collaboration with Cytiva has highlighted the power of the Affimer platform to generate diagnostic reagents quickly, and with high specificity. Additionally, it has c.20 ongoing evaluations with diagnostic partners, all off which have the potential to deliver licensing deals. Five of these have concluded well and are moving to licensing discussions. ? Outlook. The near-term outlook is dominated by the prospect of launching a SARSCoV-2 mass screening point-of-care antigen test, using a lateral flow device, in the summer, the demand for which is likely to be in the 10s of millions. ? Forecasts and valuation. We have made minor changes to FY 2020 forecasts and leave our target price under review. Modelling the potential impact of a COVID-19 antigen test with any degree of confidence at the moment is not possible; however, the upside, if a successful test(s) is/are developed is/are considered substantial, as illustrated by the £250m+ incremental value created by Novacyt’s COVID PCR test.

Covid-19 a catalyst for Ocado, says Numis

The move to online supermarket shopping has been ‘turbocharged’ by Covid-19 and Ocado (OCDO) will be a major beneficiary, says Numis.

Analyst Simon Bowler retained his ‘buy’ recommendation and target price of £24 on the shares, which rose 3.6%, or 58p, to £16.73 yesterday at the time of writing.

‘We see Covid-19 as a catalyst for both supply and demand,’ he said. ‘Consumers have had friction points forcibly removed. Grocery management teams have mandates and mindsets more geared towards the online channel.’

Bowler said that Ocado’s technology platform ‘supports a superior proposition and profitability’ and the share price is therefore ‘underpinned by conservative assumptions on the embedded value in current deals’.

=====================================================================

Lovely breakout on the chart and next leg up starting.

https://uk.advfn.com/p.php?pid=legacydaily&epic=L^OCDO&type=4&size=3&period=4&ind_type1=1&ind1_1=&ind2_1=&olx_1=3&ma_type1=3&o_1maday1=10&o_2maday1=&o_colour1=1&olx_2=3&ma_type2=3&o_1maday2=50&o_2maday2=&o_colour2=2&olx_3=3&ma_type3=3&o_1maday3=20&o_2maday3=&o_colour3=3&scheme=&delay_indices=DELAYED_INDICES

Covid-19 a catalyst for Ocado, says Numis

The move to online supermarket shopping has been ‘turbocharged’ by Covid-19 and Ocado (OCDO) will be a major beneficiary, says Numis.

Analyst Simon Bowler retained his ‘buy’ recommendation and target price of £24 on the shares, which rose 3.6%, or 58p, to £16.73 yesterday at the time of writing.

‘We see Covid-19 as a catalyst for both supply and demand,’ he said. ‘Consumers have had friction points forcibly removed. Grocery management teams have mandates and mindsets more geared towards the online channel.’

Bowler said that Ocado’s technology platform ‘supports a superior proposition and profitability’ and the share price is therefore ‘underpinned by conservative assumptions on the embedded value in current deals’.

I mentioned Kape KAPE yesterday as a potential buy.

Just seen this post from the respected poster Rivaldo.........

============================================================================

"New Buy tip for KAPE this weekend Sun 11:25
Very positive review in this month's new SCSW.(tip sheet)

It's one of only two companies covered in the entire issue which conclude with the instruction to "Buy" (and the main tips and ideas are rubbish this month imo!).

===============================================================================

Key upcoming dates
21 May 2020 AGM / EGM

could take off on this day.